| Literature DB >> 28438465 |
Jie Song1, Sisi Jing1, Chao Quan1, Jun Lu1, Xiangyang Qiao1, Kai Qiao2, Jiahong Lu1, Jianying Xi3, Chongbo Zhao4.
Abstract
Isaacs syndrome is a form of peripheral nerve hyperexcitability, characterized by spontaneous muscle twitching and stiffness. Some patients are reported to be positive for CASPR2 antibody that may be one of the pathogenic autoantibodies in Isaacs syndrome. We reported a series of three patients with Isaacs syndrome, including their clinical features, electrophysiologic findings, laboratory parameters and therapeutic responses. All the three patients were positive for CASPR2 antibodies examined on transfected human embryonic kidney 293 cells by indirect immunofluorescence method. One patient had invasive thymoma. Symptomatic treatment was not sufficient for them, while immunotherapies including corticosteroids, double filtration plasmapheresis and rituximab provided favorable outcomes. The titers of CASPR2 antibody decreased after immune modulating therapy in parallel to clinical improvements in two patients.Entities:
Keywords: CASPR2 antibody; Immunotherapy; Isaacs syndrome
Mesh:
Substances:
Year: 2017 PMID: 28438465 DOI: 10.1016/j.jocn.2017.02.063
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961